Sevoflurane inhibits cardiac function in pulmonary fibrosis mice through the TLR4 signaling pathway

Pulmonary Circulation
Yanan CaoE Wang

Abstract

Pulmonary fibrosis is often concomitant with myocardial injury. We studied sevoflurane's effects on cardiac function and the expression of the TLR4/inducible nitric oxide synthase (iNOS) signaling pathway on a pulmonary fibrosis model. C57BL/6J wild-type (WT) and TLR4-deficient (TLR4-/-) mice were randomly divided into a control group and a pulmonary fibrosis group. The model of pulmonary fibrosis was induced by treatment with paraquat (PQ; 20 mg/kg). Four weeks after PQ administration, mice were tested for body weight changes, and histopathology and hydroxyproline in lung. Left ventricular function in each group of mice was measured by echocardiogram before and after sevoflurane inhalation. The expression of TLR4 and iNOS protein were analyzed. Pulmonary fibrosis mice were fed lenalidomide (50 mg/kg/day) for three days and cardiac function was assessed before and after sevoflurane inhalation. WT pulmonary fibrosis mice showed pathological damage and excessive deposition of collagen in the lung and heart. Left ventricular function decreased after four weeks of PQ exposure. TLR4-/- mice were resistant to pulmonary fibrosis like pathological damage and the effect of sevoflurane on heart rate and ejection fraction than that of WT ...Continue Reading

References

Oct 30, 1980·Nature·C Nüsslein-Volhard, E Wieschaus
Oct 19, 2005·Cellular and Molecular Life Sciences : CMLS·N MatsushimaR H Kretsinger
Feb 25, 2006·Cell·Shizuo AkiraOsamu Takeuchi
Mar 17, 2007·Annual Review of Biochemistry·Nicholas J Gay, Monique Gangloff
Nov 13, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bethany B Moore, Cory M Hogaboam
May 10, 2008·The American Journal of Pathology·Ayumi YoshizakiShinichi Sato
Jul 4, 2012·Saudi Journal of Anaesthesia·Ahmed S Bassuoni, Yasser M Amr
Jul 17, 2012·Journal of Ethnopharmacology·Mengli ChenWing Keung Liu
Oct 25, 2012·Annual Review of Pathology·Jeremy S DuffieldThomas A Wynn
Oct 2, 2015·The European Respiratory Journal·Ganesh RaghuSusanne Stowasser
Jan 20, 2016·Genetics and Molecular Research : GMR·X X LiH P Dai
Nov 7, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Simone EbenerManuela Funke
Jan 31, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jiru ZhangNan Dong
Mar 11, 2017·The Journal of Pharmacology and Experimental Therapeutics·Lijun TaoChaofeng Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
Protein Assay

Software Mentioned

GraphPad Prism
Image Pro Plus

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Journal of Accident & Emergency Medicine
C Moulton, P Dark
British Journal of Anaesthesia
M Daniel
Anaesthesia and Intensive Care
C Ball, R N Westhorpe
Anesthesia and Analgesia
T P Malan
© 2022 Meta ULC. All rights reserved